-
-
-
-
-
-
-
Pre-Open Movers 07/10: (OCX) (VVUS) (XLRN) Higher; (ISR) (AQXP) (IRBT) Lower (more...)
-
-
-
-
-
-
-
Celgene (CELG): 2Q Could Could See Weak Otezla Sales - Baird
-
-
-
-
-
-
-
Celgene (CELG): Revlimid Label Not Expanding to NHL - Baird
-
-
-
-
-
-
-
Notable Analyst Rating Changes 01/08: (CELG) (MGM) (LUV) Upgraded; (FIO) (DECK) (MYL) Downgraded
-
-
-
-
-
-
-
Baird Boosts Target on Celgene (CELG) On Possible Surprise Vidaza Upside
-
-
-
-
-
-
-
Notable Analyst Rating Changes 04/29: PALM, AKAM, FSLR, AFL Upgraded; AKS, VNDA, CMA Downgraded
-
-
-
-
-
-
-
Unusual 11 Mid-Day Movers 4/1: ZZ, ONTY, FCFC, LCUT Higher; TKP, SAH, GFG, APOL Lower
-
22,989 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All